Biogen introduces Spinal Muscular Atrophy (SMA) Policy and Access Tracker

Biogen has collaborated with SMA Europe to develop a tool called the Spinal Muscular Atrophy (SMA) Policy and Access Tracker, which offers an in-depth assessment of how 23 European countries are performing in terms of access to SMA treatment, care and supporting policies, identifies the major areas for improvement, and provides policy recommendations to tackle existing gaps.

The Tracker has a dedicated website featuring an interactive map and a White Paper summarising findings and presenting targeted policy recommendations.

The Tracker will be presented and discussed at a webinar entitled “Living with SMA: Spotlight on the policy and access environment in Europe” that will take place on October 05, 2021 from 11.00 – 12.30 CET. The webinar will focus on the current situation in Europe to gain a greater understanding of how to tackle existing challenges for people living with SMA.

More information and registration here: